Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neuromyelitis optica spectrum disorders with a benign course. Analysis of 544 patients.
Lana-Peixoto MA, Talim NC, Callegaro D, Marques VD, Damasceno A, Becker J, Gonçalves MVM, Sato H; Brazilian Committee for Treatment and Research in Multiple Sclerosis. Lana-Peixoto MA, et al. Among authors: goncalves mvm. Mult Scler Relat Disord. 2023 Jul;75:104730. doi: 10.1016/j.msard.2023.104730. Epub 2023 Apr 24. Mult Scler Relat Disord. 2023. PMID: 37156036
Unfavorable outcomes during treatment of multiple sclerosis with high doses of vitamin D.
Fragoso YD, Adoni T, Damasceno A, de Albuquerque Damasceno CA, Ferreira ML, Finkelzstejn A, Gomes S, Goncalves MV, Grzesiuk AK, Lins S, Mendes MF, de Oliveira FT, Parolin MF, Rocha CF, Tauil CB. Fragoso YD, et al. J Neurol Sci. 2014 Nov 15;346(1-2):341-2. doi: 10.1016/j.jns.2014.08.019. Epub 2014 Aug 23. J Neurol Sci. 2014. PMID: 25183235 No abstract available.
The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis.
Fragoso YD, Arruda CC, Arruda WO, Brooks JB, Damasceno A, Damasceno CA, Finkelsztejn A, Finkelsztejn J, Gama PD, Giacomo MC, Gomes S, Goncalves MV, Matta AP, de Morais MM, Oliveira EM, Ribeiro Y, Sato HK, Tauil CB. Fragoso YD, et al. Arq Neuropsiquiatr. 2014 Sep;72(9):712-4. doi: 10.1590/0004-282x20140102. Arq Neuropsiquiatr. 2014. PMID: 25252236 Free article.
Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis.
Fragoso YD, Adoni T, Alves-Leon SV, Apostolos-Pereira SL, Araujo YR, Becker J, Brooks JBB, Correa EC, Damasceno A, Damasceno CAA, Ferreira MLB, Gama PDD, Gama RADD, Gomes S, Goncalves MVM, Grzesiuk AK, Machado SCN, Matta APDC, Mendes MF, Ribeiro TAGJ, Rocha CFD, Ruocco HH, Sato H, Simm RF, Tauil CB, Vasconcelos CCF, Vieira VLF. Fragoso YD, et al. Among authors: goncalves mvm. Expert Rev Clin Pharmacol. 2016 Apr;9(4):541-546. doi: 10.1586/17512433.2016.1145053. Epub 2016 Feb 21. Expert Rev Clin Pharmacol. 2016. PMID: 26794493
Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders.
Fragoso YD, Adoni T, Alves-Leon SV, Apostolos-Pereira SL, Barreira AA, Brooks JB, Claudino R, Correa EC, Ferreira ML, Finkelsztejn A, Finkelsztejn J, da Gama PD, Goncalves MV, Guerreiro CT, da Cunha Matta AP, Marques VD, Rizo Morales R, Parolin MF, de Castro Ribeiro M, Ribeiro TA, Ruocco HH, Sato H, Scherpenhuijzen S, Siquineli F, de Carvalho Sousa NA, Varela DL, Tauil CB, Winckler TC. Fragoso YD, et al. NeuroRehabilitation. 2016 Jun 30;39(2):301-4. doi: 10.3233/NRE-161361. NeuroRehabilitation. 2016. PMID: 27372365
Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis.
Marques VD, Passos GRD, Mendes MF, Callegaro D, Lana-Peixoto MA, Comini-Frota ER, Vasconcelos CCF, Sato DK, Ferreira MLB, Parolin MKF, Damasceno A, Grzesiuk AK, Muniz A, Matta APDC, Oliveira BES, Tauil CB, Maciel DRK, Diniz DS, Corrêa EC, Coronetti F, Jorge FMH, Sato HK, Gonçalves MVM, Sousa NAC, Nascimento OJM, Gama PDD, Domingues R, Simm RF, Thomaz RB, Morales RR, Dias RM, Apóstolos-Pereira SD, Machado SCN, Junqueira TF, Becker J. Marques VD, et al. Among authors: goncalves mvm. Arq Neuropsiquiatr. 2018 Aug;76(8):539-554. doi: 10.1590/0004-282X20180078. Arq Neuropsiquiatr. 2018. PMID: 30231128 Free article.
Efficacy outcomes reported in trials of multiple sclerosis: A systematic scoping review.
Oliveira ML, Lucchetta RC, Bonetti AF, Fernandez-Llimós F, Becker J, Gonçalves MVM, Tauil CB, Pontarolo R, Wiens A. Oliveira ML, et al. Among authors: goncalves mvm. Mult Scler Relat Disord. 2020 Oct;45:102435. doi: 10.1016/j.msard.2020.102435. Epub 2020 Jul 30. Mult Scler Relat Disord. 2020. PMID: 32799122 Review.
Patients and neurologists have different perceptions of multiple sclerosis symptoms, care and challenges.
Marin CE, Kfouri PP, Callegaro D, Lana-Peixoto MA, Neto APG, Vasconcelos CCF, d'Almeida JAC, Gonçalves MVM, Mendes MF, Parolin MKF, Nascimento O, da Gama PD, Dias-Carneiro RPC, Dias RM, Damasceno A, San Martin G, Becker J; Brazilian Committee for Treatment and Research in Multiple Sclerosis (BCTRIMS). Marin CE, et al. Among authors: goncalves mvm. Mult Scler Relat Disord. 2021 May;50:102806. doi: 10.1016/j.msard.2021.102806. Epub 2021 Feb 3. Mult Scler Relat Disord. 2021. PMID: 33588316
71 results